Clinical Trial Update: Repeated Dose IV Baclofen Safety/Bioequivalence Study [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 study evaluating safety and bioequivalence of repeated-dose intravenous baclofen, sponsored by Allaysis, LLC. The status of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity

Drugs mentioned

• baclofen (intravenous) (baclofen)

Snippet

Sponsor: Allaysis, LLC | Conditions: Intravenous Baclofen | Phase 1, Phase 2 | Status: UNKNOWN